These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Peptide cargo administration: current state and applications. Rohira H; Arora A; Kaur P; Chugh A Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636 [TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine. Ma J; Xu J; Guan L; Hu T; Liu Q; Xiao J; Zhang Y Fish Shellfish Immunol; 2014 Jul; 39(1):8-16. PubMed ID: 24746937 [TBL] [Abstract][Full Text] [Related]
6. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response. Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734 [TBL] [Abstract][Full Text] [Related]
7. Nanovaccine: an emerging strategy. Das A; Ali N Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859 [TBL] [Abstract][Full Text] [Related]
8. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination. Wang K; Yang Y; Xue W; Liu Z Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945 [TBL] [Abstract][Full Text] [Related]
9. Cell penetrating peptide: A potent delivery system in vaccine development. Hasannejad-Asl B; Pooresmaeil F; Takamoli S; Dabiri M; Bolhassani A Front Pharmacol; 2022; 13():1072685. PubMed ID: 36425579 [TBL] [Abstract][Full Text] [Related]
10. Nanobiomaterial-based vaccination immunotherapy of cancer. Chen F; Wang Y; Gao J; Saeed M; Li T; Wang W; Yu H Biomaterials; 2021 Mar; 270():120709. PubMed ID: 33581608 [TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptides as delivery enhancers for vaccine. Jiang Y; Li M; Zhang Z; Gong T; Sun X Curr Pharm Biotechnol; 2014; 15(3):256-66. PubMed ID: 25142954 [TBL] [Abstract][Full Text] [Related]
12. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. Sadeghian I; Heidari R; Sadeghian S; Raee MJ; Negahdaripour M Eur J Pharm Sci; 2022 Feb; 169():106094. PubMed ID: 34896590 [TBL] [Abstract][Full Text] [Related]
13. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery. Kurrikoff K; Gestin M; Langel Ü Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750 [TBL] [Abstract][Full Text] [Related]
14. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Bolhassani A Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374 [TBL] [Abstract][Full Text] [Related]
15. Cell penetration: scope and limitations by the application of cell-penetrating peptides. Reissmann S J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216 [TBL] [Abstract][Full Text] [Related]
16. Comparison of six cell penetrating peptides with different properties for in vitro and in vivo delivery of HPV16 E7 antigen in therapeutic vaccines. Shahbazi S; Bolhassani A Int Immunopharmacol; 2018 Sep; 62():170-180. PubMed ID: 30015237 [TBL] [Abstract][Full Text] [Related]
17. Advances in cell penetrating peptides and their functionalization of polymeric nanoplatforms for drug delivery. Tian Y; Zhou S Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1668. PubMed ID: 32929866 [TBL] [Abstract][Full Text] [Related]
18. Advancements in prophylactic and therapeutic nanovaccines. Bhardwaj P; Bhatia E; Sharma S; Ahamad N; Banerjee R Acta Biomater; 2020 May; 108():1-21. PubMed ID: 32268235 [TBL] [Abstract][Full Text] [Related]
19. Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy. Cai T; Liu H; Zhang S; Hu J; Zhang L J Nanobiotechnology; 2021 Nov; 19(1):389. PubMed ID: 34823541 [TBL] [Abstract][Full Text] [Related]
20. Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination. Lim S; Koo JH; Choi JM Immune Netw; 2016 Feb; 16(1):33-43. PubMed ID: 26937230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]